fbpx

QQQ
+ 3.41
366.16
+ 0.92%
BTC/USD
+ 795.01
44384.54
+ 1.82%
DIA
+ 5.05
337.45
+ 1.47%
SPY
+ 5.28
432.58
+ 1.21%
TLT
-3.43
155.22
-2.26%
GLD
-1.88
167.30
-1.14%

Why Co-Diagnostics Shares Are Skyrocketing Today

July 22, 2021 2:33 pm
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More

Co-Diagnostics Inc (NASDAQ:CODX) shares are trading higher by 26.3% at $10.99 Thursday afternoon. The stock spiked earlier following reports suggesting the Biden Administration will announce it is directing $1.6 billion for COVID testing in high-risk settings.

Co-Diagnostics is a molecular diagnostics company. The company develops, licenses and commercializes molecular technologies such as lab systems (MDx device) and manufactures and sells reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA).

Co-Diagnostics low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

Co-Diagnostics has a 52-week high of $30.99 and a 52-week low of $7.01.

For the latest in financial news, exclusive stories, memes follow Benzinga on Twitter, Facebook & Instagram. For the best interviews, stock market talk & videos, subscribe to Benzinga Podcasts and our YouTube channel.

Posted-In:

Movers Trading Ideas

Related Articles

Why Co-Diagnostics Stock Is Moving Today

Co-Diagnostics, Inc. (NASDAQ: CODX) shares are trading volatile on Thursday. Hindenburg Research announced a short position in the stock. Also, the company's coronavirus test was recently approved in Mexico. read more
46 Biggest Movers From Yesterday

46 Biggest Movers From Yesterday

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares climbed 189.5% to close at $9.90 on Wednesday after surging over 15% on Tuesday. read more
78 Biggest Movers From Friday

78 Biggest Movers From Friday

Gainers PharmaCyte Biotech, Inc. (NASDAQ: PMCB) shares jumped 43.4% to close at $3.27. PharmaCyte Biotech recently reported closing of $15-million public offering. read more
Co-Diagnostics Stock Moves Higher As Q2 Earnings Top Estimates

Co-Diagnostics Stock Moves Higher As Q2 Earnings Top Estimates